´óÏó´«Ã½

´óÏó´«Ã½ has been appointed as a marketing partner for s Cyrolite, Cyrolite MD and XT portfolio of advanced medical acrylic-based polymers for the North American healthcare market. Foster will provide sales, technical support, and order fulfillment support from its U.S. locations in Connecticut and Nevada.

Röhm’s medical grade Cyrolite brand is one of the most complete and durable lines of acrylic-based technologies in the medical material segment and has been in production for more than 50 years. Over its history, the Röhm portfolio has proven to be a reliable and trustworthy resource for applications where transparency, toughness, chemical resistance (alcohol and lipid resistance), gamma/EtO sterilization, and processability are key specification criteria. In addition, every product in Röhm’s extensive healthcare product portfolio are bio tested to USP Class VI and ISO 10993.

Said Thomas Hemler, Röhm’s global segment director for medical molding compounds, “We’re excited to partner with the Foster team which will provide improved distribution of Röhm’s Cyrolite brand to our customers in key medical application segments. Our Cyrolite product applications range from blood and IV filter housings, fluid connectors, IVD & microfluidic chips - to orthopedic trays and combination devices for medical device disposables, diagnostics, drug delivery, respiratory & anesthesiology, and medical packaging.”